+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term anti-inflammatory drug use and Helicobacter pylori infection: a clinical, endoscopic and histological study



Long-term anti-inflammatory drug use and Helicobacter pylori infection: a clinical, endoscopic and histological study



Indian Journal of Gastroenterology 15(4): 118-121



Non-steroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori are independent risk factors for gastroduodenal damage and peptic ulcer. To study the frequency and effect of H pylori infection on gastroduodenal mucosa in patients on long-term NSAID use. A total of 125 subjects were studied: 65 patients (Group 1) on NSAID therapy (> 6 months), 30 patients (Group 2) with arthritic disorders prior to starting NSAID therapy, and 30 healthy volunteers (Group 3). Dyspeptic symptoms were evaluated using a questionnaire. All patients underwent endoscopy and antral and duodenal biopsies were obtained to assess the extent of gastroduodenal damage and H pylori status. H pylori infection was less frequent in Group 1 (37%) compared to Group 2 (57%, p = ns) and 3 (60%, p < 0.05). Among Group 1 patients, H pylori infection did not increase the risk of gastroduodenal damage (52% vs 45%) or ulceration (32% vs 27%). Group 1 patients with H pylori infection were more likely to be symptomatic (48% vs 27%) and have chronic active gastritis (76% vs 12%) and chronic active duodenitis (68% vs 5%). Gastric metaplasia was seen only in patients with H pylori infection, chronic active gastritis and duodenitis. Chemical gastritis was observed more commonly in Group 1 (34% vs 3%) compared to Group 2; its was not seen in Group 3. H pylori infection was less commonly observed in patients with chemical gastritis (8% vs 50%). Patients on long-term NSAIDs are not at increased risk of H pylori infection. Presence H pylori infection is not associated with increased risk of gastroduodenal damage in these patients. H pylori infection correlated with presence of chronic active gastritis, and NSAID with presence of chemical gastritis.

(PDF emailed within 1 workday: $29.90)

Accession: 046567507

Download citation: RISBibTeXText

PMID: 8916573


Related references

Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 102(6): 1899-1905, 1992

Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis. Modern Rheumatology 17(3): 228-234, 2007

Helicobacter pylori infection and the development of gastric cancer - Long term endoscopic follow up study. Gastroenterology 116(4 PART 2): A522, April, 1999

Helicobacter pylori infection and the development of gastric cancer Second report Long term endoscopic follow up study. Gastroenterology 118(4 Suppl 2 Part 1): AGA A726, April, 2000

Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Digestive Diseases and Sciences 41(8): 1589-1594, 1996

Does eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy reduce the long-term risk of ulcers? A double-blinded randomized trial. Gastroenterology 120(5 Supplement 1): A 143, April, 2001

Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis. International Journal of Clinical Pharmacology and Therapeutics 44(4): 149-153, 2006

Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: A long-term prospective study. Alimentary Pharmacology & Therapeutics 15(12): 1875-1882, December, 2001

Relationship between progression of gastric mucosal atrophy and Helicobacter pylori infection: retrospective long-term endoscopic follow-up study. Journal of Gastroenterology 32(1): 19-23, 1997

Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study. Journal of Gastroenterology & Hepatology 18(1): 18-25, January, 2003

Non-steroidal anti-inflammatory drug gastropathy and Helicobacter pylori infection. Italian Journal of Gastroenterology and Hepatology 31 Suppl 1: S23-S26, 1999

Helicobacter pylori infection in nonsteroidal anti-inflammatory drug users. Korean Journal of Gastroenterology 64(2): 70-75, 2016

Long-term use of nonsteroidal anti-inflammatory drugs normalizes the kinetics of gastric epithelial cells in patients with Helicobacter pylori infection via attenuation of gastric mucosal inflammation. Journal of Gastroenterology 44 Suppl 19(): 8-17, 2009